LIME1
Lck-interacting transmembrane adapter 1
Also known as: dJ583P15.4, FLJ20406, LIME, LIME1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9H400
- Gene
- LIME1
- Ensembl
- ENSG00000203896
- Chromosome
- 20
- Canonical length
- 295 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
This gene encodes a transmembrane adaptor protein that links the T and B-cell receptor stimulation to downstream signaling pathways via its association with the Src family kinases Lck and Lyn, respectively. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Mar 2015]
Canonical amino-acid sequenceUniProt
295 residues, UniProt reviewed canonical sequence.
>Q9H400|LIME1
1 MGLPVSWAPP ALWVLGCCAL LLSLWALCTA CRRPEDAVAP RKRARRQRAR LQGSATAAEA
61 SLLRRTHLCS LSKSDTRLHE LHRGPRSSRA LRPASMDLLR PHWLEVSRDI TGPQAAPSAF
121 PHQELPRALP AAAATAGCAG LEATYSNVGL AALPGVSLAA SPVVAEYARV QKRKGTHRSP
181 QEPQQGKTEV TPAAQVDVLY SRVCKPKRRD PGPTTDPLDP KGQGAILALA GDLAYQTLPL
241 RALDVDSGPL ENVYESIREL GDPAGRSSTC GAGTPPASSC PSLGRGWRPL PASLPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against LIME1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.71
- Highest tissue expression
- 259 nTPM
Expression across tissuesHPA
Tissue
- liver: 259 nTPM
- kidney: 57 nTPM
- spleen: 42 nTPM
- cerebellum: 28 nTPM
- basal ganglia: 25 nTPM
- small intestine: 18 nTPM
Single-cell type
- conjunctival goblet cells: 1 nCPM
- plasma cells: 0.4 nCPM
- astrocytes: 0.2 nCPM
- nk-cells: 0.2 nCPM
- t-cells: 0.2 nCPM
- brain excitatory neurons: 0.1 nCPM
Immune cell
- plasmacytoid DC: 751 nTPM
- T-reg: 691 nTPM
- memory CD4 T-cell: 439 nTPM
- memory CD8 T-cell: 412 nTPM
- naive CD8 T-cell: 320 nTPM
- gdT-cell: 316 nTPM
Brain region
- basal ganglia: 15 nTPM
- white matter: 13 nTPM
- cerebral cortex: 13 nTPM
- thalamus: 11 nTPM
- medulla oblongata: 9.6 nTPM
- cerebellum: 9.2 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.65
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.06
- DepMap mean gene effect
- 0.13
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adaptive immune response
- B cell receptor signaling pathway
- regulation of canonical NF-kappaB signal transduction
- regulation of non-canonical NF-kappaB signal transduction
- regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction
- regulation of release of sequestered calcium ion into cytosol
- regulation of transcription by RNA polymerase II
- T cell receptor signaling pathway
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Lck-interacting transmembrane adapter 1
- Lck-interacting transmembrane adapter 1
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of LIME1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads LIME1 as an antibody target. Whether an autoantibody or antibody against LIME1 could matter depends on whether native LIME1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
LIME1 is annotated at the cell surface, where native LIME1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label LIME1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...